newsfilter
← Latest News
PR Newswire·

I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

I-Mab (NASDAQ: IMAB), a US-based, global, clinical-stage biotech company, exclusively focused on the development of highly differentiated...